Enrica Marchi

ScholarGPS® ID: 73081551031209

Affiliation

University of Virginia, Charlottesville, United States

Affiliation History

Field

Medicine

Discipline

Hematology

Top Specialties

Metrics Summary

Publication Count

Predicted Citations

2,971

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Mature T-cell and NK-cell lymphoma involvement of the central nervous system: a single center experience (journal article) Ma, Helen \| Marchi, Enrica \| O’Connor, Owen A. \| Lue, Jennifer K. Leukemia & Lymphoma, volume 64, issue 12, pages 1964-1970 (2023). 10.1080/10428194.2023.2245513 Cited by (1) \| Cite \| Source
PTCL and ICIs: a matter of time and subtype (journal article) Marchi, Enrica Blood, volume 142, issue 7, pages 613-614 (2023). 10.1182/blood.2023021304 Cite \| Source
Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma (journal article) Kalac, Matko \| Jain, Salvia \| Tam, Constantine S. \| Xiao, Zhengrui \| Montanari, Francesca \| Kanakry, Jennifer \| Huber, Bryan D. \| Goldfinger, Mendel \| O’Connor, Owen A. \| Marchi, Enrica Blood Advances, volume 7, issue 14, pages 3760-3763 (2023). 10.1182/bloodadvances.2022009445 Cited by (6) \| Cite \| Source
Synthesis and Preclinical Development of a Promising Novel Romidepsin Nanoparticle for the Treatment of Peripheral T‐Cell Lymphoma (PTCL) (journal article) O'Connor, O. A. \| Illendula, A. \| Jayappa, K. D. \| Fox, T. E. \| Loughran, T. P. \| Feith, D. J. \| Marchi, E. \| Pal, I. Hematological Oncology, volume 41, issue S2, pages 548-548 (2023). 10.1002/hon.3164_409 Cite \| Source
Identifying the mechanistic differences between hypomethylating agents for the treatment of peripheral T cell lymphoma (journal article) Pal, I. \| Scotto, L. \| Sabzevari, A. \| Kinahan, C. \| Fox, T. E. \| Feith, D. J. \| Marchi, E. \| Loughran, T. P. \| O'Connor, O. A. Hematological Oncology, volume 41, issue S2, pages 313-314 (2023). 10.1002/hon.3164_220 Cite \| Source
Pembrolizumab in combination with epigenetic therapy is safe and active in heavily treated patients with peripheral T‐cell lymphoma and cutaneous T‐cell lymphoma (journal article) Roberts, N. L. \| Lister, J. \| Benani, N. N. \| Jain, S. \| Battaglia, T. \| Abdelmalek, M. \| Ayers, E. C. \| Portell, C. \| Williams, M. E. \| Batchala, P. \| ... \| Marchi, E. Hematological Oncology, volume 41, issue S2, pages 269-270 (2023). 10.1002/hon.3164_181 Cite \| Source
PB2358: PHASE 1-2 STUDY OF THE SAFETY, PK, PD, AND PRELIMINARY ACTIVITY OF TOLINAPANT IN COMBINATION WITH ORAL DECITABINE/CEDAZURIDINE AND ORAL DECITABINE/CEDAZURIDINE ALONE IN SUBJECTS WITH R/R PTCL (journal article) Shortt, Jake \| Poligone, Brian \| Ribrag, Vincent \| Zinzani, Pier Luigi \| El-Sharkawi, Dima \| Walewski, Jan \| Prica, Anca \| Wilson, Laksmi \| Souza, Sonia \| Keer, Harold \| ... \| Marchi, Enrica HemaSphere, volume 7, issue S3, pages e07947e7- (2023). 10.1097/01.HS9.0000976148.07947.e7 Cite \| Source
The Novel Nano-Formulation of the HDAC Inhibitor, Romidepsin, for the Treatment of Relapsed, Refractory Peripheral T-Cell Lymphoma (journal article) Pal, Ipsita \| Illendula, Anuradha \| Manavalan, John Sanil \| Fox, Todd P \| O'Connor, Owen A. \| Loughran, Thomas P. \| Kester, Mark \| Feith, David J \| Marchi, Enrica Blood, volume 140, issue Supplement 1, pages 8848-8849 (2022). 10.1182/blood-2022-167628 Cite \| Source
A Phase 1-2, Open-Label Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Activity of Tolinapant in Combination with Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Subjects with Relapsed/Refractory Peripheral (journal article) Shortt, Jake \| Poligone, Brian \| Ribrag, Vincent \| Zinzani, Pier Luigi \| El-Sharkawi, Dima \| Walewski, Jan \| Prica, Anca \| Wilson, Laksmi \| Souza, Sonia \| Keer, Harold N. \| ... \| Marchi, Enrica Blood, volume 140, issue Supplement 1, pages 12033-12034 (2022). 10.1182/blood-2022-158650 Cite \| Source
Tolinapant, a Non-Peptidomimetic Antagonist of Inhibitors of Apoptosis Proteins, cIAP1/2 and XIAP, in Combination with the Hypomethylating Agents, Azacytidine and Decitabine Are Highly Synergistic in in Vitro Models of T Cell Lymphoma (journal article) Manavalan, John Sanil \| Pal, Ipsita \| Pursley, Aidan \| Ward, George A. \| Smyth, Tomoko \| Sims, Martin \| Taylor, Jason A. \| Feith, David J \| Loughran, Thomas P. \| O'Connor, Owen A. \| Marchi, Enrica Blood, volume 140, issue Supplement 1, pages 11552-11553 (2022). 10.1182/blood-2022-169906 Cite \| Source
A Real World Experience of Combined Treatment with Romidepsin and Azacitidine in Patients with Peripheral T-Cell Lymphoma - a Bridge to Transplant and an Effective Salvage for the Unfit (journal article) Kalac, Matko \| Jain, Salvia \| Tam, Constantine S. \| Goldfinger, Mendel \| Xiao, Zhengrui \| Montanari, Francesca \| Huber, Bryan D. \| Kanakry, Jennifer A. \| O'Connor, Owen A. \| Marchi, Enrica Blood, volume 140, issue Supplement 1, pages 9422-9424 (2022). 10.1182/blood-2022-165165 Cited by (1) \| Cite \| Source
Pembrolizumab in Combination with Epigenetic Therapy Is Safe and Active in Heavily Treated Patients with Peripheral T-Cell Lymphoma (PTCL) and Cutaneous T-Cell Lymphoma (CTCL): Preliminary Results from the Embolden Trial (journal article) Roberts, Nathan \| Lister, John \| Bennani, N. Nora \| Jain, Salvia \| Battaglia, Tammy \| Ayers, Emily C. \| Portell, Craig A. \| Williams, Michael E. \| Batchala, Prem \| Pal, Ipsita \| ... \| Marchi, Enrica Blood, volume 140, issue Supplement 1, pages 9425-9426 (2022). 10.1182/blood-2022-170181 Cited by (2) \| Cite \| Source
A real-world experience of combined treatment with romidepsin and azacitidine in patients with peripheral T-cell lymphoma. (journal article) Kalac, Matko \| Tam, Constantine Si Lun \| Goldfinger, Mendel \| Xiao, Zhengrui \| Rajeeve, Sridevi \| Montanari, Francesca \| Kanakry, Jennifer Ann \| O'Connor, Owen \| Marchi, Enrica Journal of Clinical Oncology, volume 40, issue 16_suppl, pages e19550-e19550 (2022). 10.1200/JCO.2022.40.16_suppl.e19550 Cited by (1) \| Cite \| Source
The combination of the IAP antagonist, tolinapant and hypomethylating agents (HMA) is highly synergistic in in vitro models of T-cell lymphoma (TCL). (journal article) Manavalan, John \| Pal, Ipsita \| Pursley, Aidan \| Ward, George \| Smyth, Tomoko \| Sims, Martin \| Feith, David \| Loughran, Thomas \| O’Connor, Owen \| Marchi, Enrica Journal of Clinical Oncology, volume 40, issue 16_suppl, pages e15088-e15088 (2022). 10.1200/JCO.2022.40.16_suppl.e15088 Cite \| Source
Clonal cutaneous and neurosyphilis: A pitfall in pseudolymphoma diagnosis (journal article) Yi, Lauren G. \| Rusu, Corina A. \| Cropley, Thomas G. \| Marchi, Enrica \| Gru, Alejandro A. \| Greer, Kenneth E. \| Raghavan, Shyam S. Journal of Cutaneous Pathology, volume 49, issue 3, pages 288-292 (2022). 10.1111/cup.14153 Cited by (3) \| Cite \| Source
P1195: A REAL WORLD EXPERIENCE OF COMBINED TREATMENT WITH ROMIDEPSIN AND AZACITIDINE IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA. (journal article) Kalac, M. \| Tam, C. \| Goldfinger, M. \| Xiao, Z. \| Rajeeve, S. \| Montanari, F. \| Kanakry, J. \| O’Connor, O. \| Marchi, E. HemaSphere, volume 6 (2022). 10.1097/01.HS9.0000847644.74540.4d Cite \| Source
P1278: ACTIVATION OF THE NECROPTOSIS PATHWAY PLAYS A ROLE IN SYNERGISM WITH COMBINATION OF THE IAP ANTAGONIST, TOLINAPANT AND HYPOMETHYLATING AGENTS (HMA) IN IN VITRO MODELS OF T-CELL LYMPHOMA (TCL). (journal article) Manavalan, J. S. \| Pal, I. \| Pursley, A. \| Ward, G. \| Smyth, T. \| Sims, M. \| Feith, D. \| Loughran, T. P. \| O’Connor, O. A. \| Marchi, E. HemaSphere, volume 6 (2022). 10.1097/01.HS9.0000847976.26425.20 Cite \| Source
The peripheral T-cell lymphoma: can we pivot from the chemotherapy-predicated paradigm? (journal article) Ma, Helen \| Marchi, Enrica Journal of Cancer Metastasis and Treatment, volume 8, issue 5, pages 25- (2022). 10.20517/2394-4722.2022.17 Cite \| Source
Peripheral T-Cell Lymphoma Involvement of the Central Nervous System: Impact of Novel Therapeutics on Clinical Outcomes (journal article) Lue, Jennifer Kimberly \| Ma, Helen \| Marchi, Enrica \| Spivack, John H \| O'Connor, Owen A. Blood, volume 138, issue Supplement 1, pages 2469-2469 (2021). 10.1182/blood-2021-144933 Cited by (1) \| Cite \| Source
Tolinapant (ASTX660), a Non-Peptidomimetic Antagonist of cIAP1/2 and XIAP, and the HDAC Inhibitor Romidepsin Are Synergistic in in Vitro Models of T Cell Lymphoma (journal article) Manavalan, John S \| Pal, Ipsita \| Pursley, Aidan \| Ward, George A. \| Smyth, Tomoko \| Sims, Martin \| Feith, David J \| Loughran, Thomas P. \| O'Connor, Owen A. \| Marchi, Enrica Blood, volume 138, issue Supplement 1, pages 4356-4356 (2021). 10.1182/blood-2021-153451 Cite \| Source